Digestible Sensor Market Report 2025

The digestible sensor market size has grown rapidly in recent years. It will grow from $1.2 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, increasing demand for non-invasive health monitoring, growing adoption of smartphones, an expanding aging population, and the increasing need for personalized medicine.

The digestible sensor market size is expected to see rapid growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to increasing consumer demand for health tracking, rising adoption of wearable devices, expansion of healthcare data analytics, growth in personalized healthcare, increasing demand for real-time health monitoring, rising telemedicine usage, and the growing need for continuous patient monitoring. Major trends during this period include advancements in sensor technology, improvements in biosensor capabilities, integration of AI in health data analysis, miniaturization of sensors, progress in wearable health devices, and innovations in digital therapeutics.

The increasing demand for remote health monitoring is expected to propel the growth of the digestible sensor market going forward. Remote health monitoring involves using technology to track and manage a patient’s health outside traditional healthcare settings, allowing care from a distance. The rise in remote health monitoring is driven by people preferring personalized, real-time healthcare at home and cost-effective alternatives to in-person visits. Digestible sensors support remote health monitoring by providing real-time data on gastrointestinal function, enabling early detection of infections or diseases without invasive procedures. For instance, in June 2022, The Health Innovation Network reported that over 286,000 people in 2021/22 received support at home through technology-enabled remote monitoring, rapidly expanded under the leadership of the National Innovation Collaborative for digital health. Therefore, the increasing demand for remote health monitoring is driving the growth of the digestible sensor market.

The growing demand for personalized medicine is also expected to propel the digestible sensor market. Personalized medicine uses information about a person’s genes and lifestyle to tailor treatments and healthcare to individual needs. The rise of personalized medicine is driven by patients seeking technologies that allow real-time monitoring and customized treatment based on their unique biology. Digestible sensors enable personalized medicine by providing physicians with real-time internal data, supporting accurate diagnoses and individualized care. For instance, in February 2023, the Personalized Medicine Coalition reported that in 2022, 12 new personalized medicines were approved, representing 34% of all newly approved therapies, reflecting a substantial increase from previous years. Therefore, the growing demand for personalized medicine is driving the digestible sensor market.

Major companies in the market are developing miniaturized, multi-parameter ingestible sensors to improve gut health monitoring and diagnostic accuracy. Multi-parameter sensors simultaneously measure multiple physical or chemical parameters in a compact device. For instance, in May 2025, the Interuniversity Microelectronics Centre in Belgium unveiled a highly miniaturized ingestible sensor measuring 2.1 cm in length and 0.75 cm in diameter about three times smaller than traditional endoscopic capsules. The capsule integrates sensors for oxidation-reduction potential (ORP), pH, and temperature, recording readings every 20 seconds throughout digestion. Equipped with wireless data transmission, a biocompatible casing, low-energy electronics, and a compact battery, it enables continuous, noninvasive monitoring of internal gut conditions, supporting early diagnosis of inflammation, oxidative stress, and microbiome imbalances.

Major players in the digestible sensor market are Medtronic plc, Koninklijke Philips N.V., Otsuka Pharmaceutical Co Ltd., Olympus Corporation, Sencure B.V., Millar Inc., Check Cap Ltd, Proteus Digital Health Inc., CapsoVision Inc., Atmo Biosciences, IntroMedic Co Ltd., RF Co. Ltd, BodyCAP S.A.S, Capsule Technologies Inc., etectRx Inc., Motus GI Inc., SmartPill Corporation, JINSHAN Science & Technology (Group) Co Ltd., MC10, and HQ Inc.

North America was the largest region in the digestible sensor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the digestible sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A digestible sensor is a small, ingestible electronic device designed to be swallowed to monitor internal health conditions or provide specific diagnostic information. These sensors are often embedded in pills and can measure physiological parameters such as temperature, pH, or medication adherence while passing through the gastrointestinal (GI) tract.

The primary types of digestible sensors include capsule sensors, wearable sensors, ingestible sensors, and implantable sensors. Capsule sensors are miniaturized, ingestible devices shaped like a capsule that travel through the GI tract. These devices are distributed through channels such as online retail, pharmacies, hospitals and clinics, and direct sales. They utilize technologies including microelectromechanical systems (MEMS), wireless communication, optical sensors, and bioelectronic interfaces, and are applied in medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, serving end users such as healthcare providers, research institutions, pharmaceutical companies, and individual consumers.

The digestible sensor market research report is one of a series of new reports that provides digestible sensor market statistics, including digestible sensor industry global market size, regional shares, competitors with a digestible sensor market share, digestible sensor market segments, market trends and opportunities, and any further data you may need to thrive in the digestible sensor industry. This digestible sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digestible sensor market consists of sales of ingestion event marker (IEM), electronic pills, and ingestible thermometers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.